Tonix Pharmaceuticals Announces Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics
Dissecting the Immune Response to SARS-CoV-2 in Healthy Recovered or Asymptomatic Volunteers May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics
Potential for Human Monoclonal Antibody COVID-19 Therapeutics to be Developed as a Result of the Collaboration.
today announced it has entered into a research collaboration and option agreement with Columbia University
The research is designed to fill in important gaps in understanding the detailed immune responses to COVID-19, and to provide a foundation upon which to target vaccines and therapeutics to appropriate individuals by precision medicine.
tonixpharma.com/news-events/press-releases/detail/1215/tonix-pharmaceuticals-announces-research-collaboration-to
alphastocknews.com/tonix-pharmaceuticals-tnxp-stock-rockets-on-covid-19-news/3791/
Dissecting the Immune Response to SARS-CoV-2 in Healthy Recovered or Asymptomatic Volunteers May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics
Potential for Human Monoclonal Antibody COVID-19 Therapeutics to be Developed as a Result of the Collaboration.
today announced it has entered into a research collaboration and option agreement with Columbia University
The research is designed to fill in important gaps in understanding the detailed immune responses to COVID-19, and to provide a foundation upon which to target vaccines and therapeutics to appropriate individuals by precision medicine.
tonixpharma.com/news-events/press-releases/detail/1215/tonix-pharmaceuticals-announces-research-collaboration-to
alphastocknews.com/tonix-pharmaceuticals-tnxp-stock-rockets-on-covid-19-news/3791/
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.